COMMUNIQUÉS West-GlobeNewswire

Following Record Q2 Results, Nova Leap Health Corp. Announces Execution of Definitive Agreement to Acquire Home Care Business in Massachusetts

25/09/2019 - 23:23

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN HALIFAX, Nova Scotia, Sept. 25, 2019 (GLOBE NEWSWIRE) -- NOVA [...]

Emergent BioSolutions Awarded $20 Million to Develop Diazepam Auto-Injector to Treat Nerve Agent-Induced Seizures for U.S. Department of Defense

25/09/2019 - 22:15

GAITHERSBURG, Md., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has been awarded approximately $20 million to develop and manufacture an auto-injector containing [...]

Dova Pharmaceuticals to Present at 2019 Cantor Global Healthcare Conference

25/09/2019 - 22:15

DURHAM, N.C., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced that Jason Hoitt, Chief Commercial Officer, will present a company overview at the 2019 Cantor Global Healthcare [...]

Myriad Genetics Expands Board of Directors with Two Additional Members

25/09/2019 - 22:05

Colleen F. Reitan and Lee N. Newcomer, M.D., Elected to Myriad’s Board of Directors SALT LAKE CITY, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the “Company”), a global leader in [...]

Dentsply Sirona Announces Appointment of Janet Vergis as New Board Member

25/09/2019 - 22:05

CHARLOTTE, N.C., Sept. 25, 2019 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that Janet S. Vergis has been appointed to its Board of [...]

Xenon Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference

25/09/2019 - 22:05

BURNABY, British Columbia, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon's Chief Executive [...]

AGTC to Present at Upcoming Conferences

25/09/2019 - 22:05

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus ( [...]

Axovant Gene Therapies to Present at 2019 Cell & Gene Meeting on the Mesa

25/09/2019 - 22:05

BASEL, Switzerland, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (Nasdaq: AXGT), a clinical-stage company developing innovative gene therapies, today announced that Parag Meswani, Pharm.D., senior vice [...]

Helius Medical Technologies, Inc. and HealthTech Connex Announce Grand Opening of Canada’s Fifth PoNS Treatment™ Clinic

25/09/2019 - 22:05

Demand for traumatic brain injury management brings revolutionary neurological health technologies to Canada’s capital OTTAWA, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. and HealthTech Connex, [...]

Auxly Closes C$123 Million Investment and R&D Partnership with Imperial Brands and Strengthens its Board

25/09/2019 - 20:45

VANCOUVER, British Columbia, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (“ Auxly ” or the “ Company ”) today announced that its transaction (the “ Transaction ”) with [...]

Supernus to Present at the 2019 Cantor Global Healthcare Conference

25/09/2019 - 20:21

ROCKVILLE, Md., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]

Guerbet: 2019 half-year results

25/09/2019 - 19:15

2019 half-year results Activity growth Reported revenue of €400.6 million, up 2.8%, in line with the annual objectives Revenue of €396.5 million at constant exchange rates, up 1.8% Results in line with GEAR 2023 €61.6 [...]

GUERBET: Résultats semestriels 2019

25/09/2019 - 19:15

Résultats semestriels 2019 Croissance de l’activité Chiffre d’affaires publié de 400,6 M€ en progression de 2,8%, conformément aux objectifs annuels Chiffre d’affaires à taux de change constant de 396,5 M€ en [...]

EssilorLuxottica: 2019 Capital Markets Day - EssilorLuxottica is uniquely positioned to transform and accelerate the industry through its open business model

25/09/2019 - 19:00

2019 Capital Markets Day EssilorLuxottica is uniquely positioned to transform and accelerate the industry through its open business model Integration well under way with progress in several areas and initial decisions [...]

EssilorLuxottica : Journée investisseurs 2019 - EssilorLuxottica déploie un modèle d’affaires ouvert unique permettant de transformer et d’accélérer la croissance de l’industrie de l’optique

25/09/2019 - 19:00

Journée investisseurs 2019 EssilorLuxottica déploie un modèle d’affaires ouvert unique permettant de transformer et d’accélérer la croissance de l’industrie de l’optique Progrès de l’intégration dans plusieurs domaines [...]

Stryker to host conference call on October 29, 2019

25/09/2019 - 19:00

Kalamazoo, Michigan, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, October 29, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating [...]

GSNVI Offering First FDA Approved Trifocal IOL – PanOptix

25/09/2019 - 18:00

San Diego, Ca, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Gordon Schanzlin New Vision Institute, a TLC Laser Eye Center, leads the forefront of vision technology in San Diego with their newest Intraocular lens implant (IOL), [...]

Inventiva: H1 2019 financial results and corporate business update

25/09/2019 - 17:45

Cash and cash equivalents of €37.1 million on June 30, 2019 Successful €8.2 million capital increase enabling the Company to extend its cash runway to Q3 2020, beyond the ongoing lanifibranor and odiparcil clinical [...]

Inventiva : Résultats financiers du 1er semestre 2019 et point sur l’activité

25/09/2019 - 17:45

Trésorerie et équivalents de trésorerie à 37,1 M€ au 30 juin 2019 Succès de l’augmentation de capital de 8,2 M€ permettant à la Société d'étendre sa visibilité financière jusqu'à la fin du 3 ème trimestre 2020, au-delà [...]